Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01014429 · ClinicalTrials.gov registry record · Phase 1
Study of NMS-1286937 in Adult Patients With Advanced/Metastatic Solid Tumors
A Phase 1 study, sponsored by Nerviano Medical Sciences.
- Completed
- Registry status
- Phase 1
- Development phase
- 21
- Enrollment target
NCT01014429 is a Phase 1 study that has completed, run by Nerviano Medical Sciences. The registered enrollment target is 21 participants.
The verdict
NCT01014429, a Phase 1 study, has completed, sponsored by Nerviano Medical Sciences.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 21 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and tolerability of NMS-1286937, a polo-like-kinase 1 inhibitor, in patients with advanced metastatic solid tumor.
Interventions
- DRUG NMS-1286937
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2009-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01014429
The ClinicalTrials.gov registry entry for NCT01014429 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nerviano Medical Sciences, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which NMS-1286937 is the first listed.
NCT01014429 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01014429 about?
NCT01014429 is a clinical study titled "Study of NMS-1286937 in Adult Patients With Advanced/Metastatic Solid Tumors". The purpose of this study is to evaluate the safety and tolerability of NMS-1286937, a polo-like-kinase 1 inhibitor, in patients with advanced metastatic solid tumor.
What is the current status of trial NCT01014429?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 21 participants. The study started on 2009-11.
What interventions are being tested in trial NCT01014429?
The interventions under investigation include: NMS-1286937 (DRUG).
Who is sponsoring clinical trial NCT01014429?
This trial is sponsored by Nerviano Medical Sciences, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.